Biological Function of Glycosaminoglycans

Carbohydrate Chemistry, Biology and Medical Applications

Volumn , Issue , 2008, Pages 209-226

  Roth, Michael ^a   Papakonstantinou, Eleni ^b   Karakiulakis, George ^b  

^a WOOLCOCK INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84883959198     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-08-054816-6.00009-4     Document Type: Chapter

References (141)

1. SE Dunsmore and DE Rannels (1996) Extracellular matrix biology in the lung. Am J Physiol 270 L3-L27.
2. RJ McAnulty and GJ Laurent (1995) Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp Nephrol 3 96-107.
3. KL Schmid, JA Grundboek-Jusko Kimura, FA Tschopp, R Zollinger, JP Binette, W Lewis and S Hayashi (1982) The distribution of the glycosaminoglycans in the anatomic components of the lung and the changes in the concentration of these macromolecules during development and ageing. Biochim Biophys Acta 716 178-187.
4. JO Cantor, BA Bray, SF Ryan, I Mandl and GM Turino (1980) Glycosaminoglycan and collagen synthesis in N-nitroso-N-methylurethane induced pulmonary fibrosis. Proc Soc Exp Biol Med 164 1-8.
5. JO Cantor, O Osman, JM Cerreta, I Mandl and GM Turino (1983) Glycosaminoglycan synthesis in explants derived from bleomycin-treated fibrotic hamster lungs. Proc Soc Exp Biol Med 173 362-366.
6. N Kumar, A Bentolila and AJ Domb (2005) Structure and biological activity of heparinoid. Mini Rev Med Chem 5 441-447.
7. DL Rabenstein (2002) Heparin and heparan sulphate: structure and function. Nat Prod Rep 19 312-331.
8. ME Blewis, GE Nugent-Derfus, TA Schmidt, BL Schumacher and RL Sah (2007) A model of synovial fluid lubricant composition in normal and injured joints. Eur Cell Mater 13 26-39.
9. F Wang, LA Garza, S Kang, J Varani, JS Orringer, GJ Fisher and JJ Voorhees (2007) In vivo stimulation of de novo collagen production caused by cross-linked hyaluronic acid dermal filler injections in photodamaged human skin. Arch Dermatol 143 155-163.
10. T Ito, IP Fraser, Y Yeo, CB Highley, E Bellas and DS Kohane (2007) Anti-inflammatory function of an in situ cross-linkable conjugate hydrogel of hyaluronic acid and dexamethasone. Biomaterials 28 1778-1786.
11. PC Vitanzo Jr and BJ Sennett (2006) Hyaluronans: is clinical effectiveness dependent on molecular weight. Am J Orthop 35 421-428.
12. Y Kato, S Nakamura and M Nishimura (2006) Beneficial actions of hyaluronan (HA) on arthritic joints: effects of molecular weight of HA on elasticity of cartilage matrix. Biorheology 43 347-354.
13. B Joddar and A Ramamurthi (2006) Fragment size- and dose-specific effects of hyaluronan on matrix synthesis by vascular smooth muscle cells. Biomaterials 27 2994-3004.
14. PM Berninsone and CB Hirschberg (2000) Nucleotide sugar transporters of the Golgi apparatus. Curr Opin Struct Biol 10 542-547.
15. K Sugahara and H Kitagawa (2000) Recent advances in the study of the biosynthesis and functions of d-glycosaminoglycans. Curr Opin Struct Biol 10 518-527.
16. N Itano and K Kimata (2002) Mammalian hyaluronan synthases. IUBMB Life 54 195-199.
17. PL DeAngelis (1999) Hyaluronan synthases: fascinating glycosyltransferases from vertebrates, bacterial pathogens, and algal viruses. Cell Mol Life Sci 56 670-682.
18. M Kusche-Gullberg and L Kjellen (2003) Sulfotransferases in glycosaminoglycan biosynthesis. Curr Opin Struct Biol 13 605-611.
19. JE Silbert and G Sugumaran (2002) Biosynthesis of chondroitin/dermatan sulfate. IUBMB Life 54 177-186.
20. JL Funderburgh (2002) Keratan sulfate biosynthesis. IUBMB Life 54 187-194.
21. K Sugahara, S Yamada, K Yoshida, P de Waard and JF Vliegenthart (1992) A novel sulfated structure in the carbohydrate-protein linkage region isolated from porcine intestinal heparin. J Biol Chem 267 1528-1533.
22. K Prydz and KT Dalen (2000) Synthesis and sorting of proteoglycans. J Cell Sci 113 193-205.
23. CI Gama and LC Hsieh-Wilson (2005) Chemical approaches to deciphering the glycosaminoglycan code. Curr Opin Chem Biol 9 609-619.
24. R Sasisekharan, R Raman and V Prabhakar (2006) Glycomics approach to structure–function relationships of glycosaminoglycans. Annu Rev Biomed Eng 8 181-231.
25. S Fujita, T Iizuka and W Dauber (2001) Localization of keratan sulphate and chondroitin-6-sulphate on the anteriorly, displaced human temporomandibular joint disc–histological and, immunohistochemical analysis. J Oral Rehabil 28 962-970.
26. MT Bayliss, C Davidson, SM Woodhouse and DJ Osborne (1995) Chondroitin sulphation in human joint tissues varies with age, zone and topography. Acta Orthop Scand Suppl 266 22-25.
27. CE Bandtlow and DR Zimmermann (2000) Proteoglycans in the developing brain: new conceptual insights for old proteins. Physiol Rev 80 1267-1290.
28. KE Rhodes and JW Fawcett (2004) Chondroitin sulphate proteoglycans: preventing plasticity or protecting the CNS. J Anat 204 33-48.
29. H Kawashima, M Hirose, J Hirose, D Nagakubo, AH Plaas and M Miyasaka (2000) Binding of a large chondroitin sulphate/dermatan sulphate proteoglycan, versican, to L-selectin, P-selectin, and CD44. J Biol Chem 275 35448-35456.
30. J Iida, KL Wilhelmson, J Ng, P Lee, C Morrison, E Tam, CM Overall and JB McCarthy (2007) Cell surface chondroitin sulfate glycosaminoglycan in melanoma: role in the activation of pro-MMP-2 (pro-gelatinase A). Biochem J 403 553-563.
31. E Rodriguez, SK Roland, A Plaas and PJ Roughley (2006) The glycosaminoglycan attachment regions of human aggrecan. J Biol Chem 28127 18444-18450.
32. HE Miwa, TA Gerken, TD Huynh, DM Flory and TM Hering (2006) Mammalian expression of full-length bovine aggrecan and link protein: formation of recombinant proteoglycan aggregates and analysis of proteolytic cleavage by ADAMTS-4 and MMP-13. Biochim Biophys Acta 1760 472-486.
33. RP Somerville, JM Longpre, ED Apel, RM Lewis, LW Wang, JR Sanes, R Leduc and SS Apte (2004) ADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulphate proteoglycan containing a mucin domain. J Biol Chem 279 35159-35175.
34. NB Schwartz and M Domowicz (2002) Chondrodysplasias due to proteoglycan defects. Glycobiology 124 57R-68R.
35. J Melrose, P Roughley, S Knox, S Smith, M Lord and J Whitelock (2006) The structure, location, and function of perlecan, a prominent pericellular proteoglycan of fetal, postnatal, and mature hyaline cartilages. J Biol Chem 281 36905-36914.
36. B Monzavi-Karbassi, JS Stanley, L Hennings, F Jousheghany, C Artaud, S Shaaf and T Kieber-Emmons (2007) Chondroitin sulfate glycosaminoglycans as major P-selectin ligands on metastatic breast cancer cell lines. Int J Cancer 120 1179-1191.
37. P Kiewe, NE Bechrakis, A Schmittel, P Ruf, H Lindhofer, E Thiel and D Nagorsen (2006) Increased chondroitin sulphate proteoglycan expression (B5 immunoreactivity) in metastases of uveal melanoma. Ann Oncol 17 1830-1834.
38. P Pothacharoen, S Siriaunkgul, S Ong-Chai, J Supabandhu, P Kumja, C Wanaphirak, K Sugahara, T Hardingham and P Kongtawelert (2006) Raised serum chondroitin sulfate epitope level in ovarian epithelial cancer. J Biochem 140 517-524.
39. E Fthenou, A Zafiropoulos, A Tsatsakis, A Stathopoulos, NK Karamanos and GN Tzanakakis (2006) Chondroitin sulfate A chains enhance platelet derived growth factor-mediated signalling in fibrosarcoma cells. Int J Biochem Cell Biol 38 2141-2150.
40. XZ Wu (2006) Sulfated oligosaccharides and tumor: promoter or inhibitor. Panminerva Med 48 27-31.
41. E Derrett-Smith and HL Beynon (2006) Supplements and injections for joint disease. Br J Hosp Med (Lond) 67 290-293.
42. N Volpi (2006) Therapeutic applications of glycosaminoglycans. Curr Med Chem 13 1799-1810.
43. A Das Jr and TA Hammad (2000) Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage 85 343-350.
44. D Uebelhart, M Malaise, R Marcolongo, F DeVathaire, M Piperno, E Mailleux, A Fioravanti, L Matoso and E Vignon (2004) Intermittent treatment of knee osteoarthritis with oral chondroitin sulfate: a one-year, randomized, double-blind, multicenter study versus placebo. Osteoarthr Cartil 124 269-276.
45. J Verges, E Montell, M Herrero, C Perna, J Cuevas, M Perez and I Moller (2005) Clinical and histopathological improvement of psoriasis with oral chondroitin sulfate: a serendipitous finding. Dermatol Online J 11 31.
46. MG Kinsella, SL Bressler and TN Wight (2004) The regulated synthesis of versican, decorin, and biglycan: extracellular matrix proteoglycans that influence cellular phenotype. Crit Rev Eukaryot Gene Expr 143 203-234.
47. K Sugahara, T Mikami, T Uyama, S Mizuguchi, K Nomura and H Kitagawa (2003) Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 13 612-620.
48. J Villena and E Brandan (2004) Dermatan sulfate exerts an enhanced growth factor response on skeletal muscle satellite cell proliferation and migration. J Cell Physiol 198 169-178.
49. A Saito and H Munakata (2007) Analysis of plasma proteins that bind to glycosaminoglycans. Biochim Biophys Acta 1770 241-624.
50. HY Du, SL Ji, HF Song, QN Ye and JC Cao (2007) The relationship between the structure of dermatan sulfate derivatives and their antithrombotic activities. Thromb Res 119 377-384.
51. D Ranney, P Antich, E Dadey, R Mason, P Kulkarni, O Singh, H Chen, A Constantanescu and R Parkey (2005) Dermatan carriers for neovascular transport targeting, deep tumor penetration and improved therapy. J Control Release 109 222-235.
52. Y Nomura (2006) Structural change in decorin with skin aging. Connect Tissue Res 47 249-255.
53. HB Henninger, SA Maas, CJ Underwood, RT Whitaker and JA Weiss (2007) Spatial distribution and orientation of dermatan sulfate in human medial collateral ligament. J Struct Biol 158 33-45.
54. VJ Hindson, JT Gallagher, W Halfter and PN Bishop (2005) Opticin binds to heparan and chondroitin sulfate proteoglycans. Invest Ophthalmol Vis Sci 46 4417-4423.
55. I Kashiwakura, T Teramachi, I Kakizaki, Y Takagi, TA Takahashi and K Takagaki (2006) The effects of glycosaminoglycans on thrombopoietin-induced megakaryocytopoiesis. Haematologica 91 445-451.
56. C Prante, K Bieback, C Funke, S Schon, S Kern, J Kuhn, M Gastens, K Kleesiek and C Gotting (2006) The formation of extracellular matrix during chondrogenic differentiation of mesenchymal stem cells correlates with increased levels of xylosyltransferase I. Stem Cells 24 2252-2261.
57. M Ida, T Shuo, K Hirano, Y Tokita, K Nakanishi, F Matsui, S Aono, H Fujita, Y Fujiwara, T Kaji and A Oohira (2006) Identification and functions of chondroitin sulfate in the milieu of neural stem cells. J Biol Chem 281 5982-5991.
58. L Fuentes, M Hernandez, ML Nieto and M Sanchez Crespo (2002) Biological effects of group IIA secreted phosholipase A(2). FEBS Lett 531 7-11.
59. RJ Waddington, HC Roberts, RV Sugars and E Schonherr (2003) Differential roles for small leucine-rich proteoglycans in bone formation. Eur Cell Mater 6 12-21.
60. JA Huntington (2003) Mechanisms of glycosaminoglycan activation of the serpins in hemostasis. J Thromb Haemost 1 1535-1549.
61. S Theoleyre, S Kwan Tat, P Vusio, F Blanchard, J Gallagher, S Ricard-Blum, Y Fortun, M Padrines, F Redini and D Heymann (2006) Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. Biochem Biophys Res Commun 347 460-467.
62. SF Penc, B Pomahac, E Eriksson, M Detmar and RL Gallo (1999) Dermatan sulfate activates nuclear factor-kappab and induces endothelial and circulating intercellular adhesion molecule-1. J Clin Invest 103 1329-1335.
63. Y Srinoulprasert, P Kongtawelert and SC Chaiyaroj (2006) Chondroitin sulfate B and heparin mediate adhesion of Penicillium marneffei conidia to host extracellular matrices. Microb Pathog 40 126-132.
64. EL Tonnaer, TG Hafmans, TH Van Kuppevelt, EA Sanders, PE Verweij and JH Curfs (2006) Involvement of glycosaminoglycans in the attachment of pneumococci to nasopharyngeal epithelial cells. Microbes Infect 8 316-322.
65. MJ Lodes, H Secrist, DR Benson, S Jen, KD Shanebeck, J Guderian, JF Maisonneuve, A Bhatia, D Persing, S Patrick and YA Skeiky (2006) Variable expression of immunoreactive surface proteins of Propionibacterium acnes. Microbiology 152 3667-3681.
66. JR Fischer, KT LeBlanc and JM Leong (2006) Fibronectin binding protein BBK32 of the Lyme disease spirochete promotes bacterial attachment to glycosaminoglycans. Infect Immun 74 435-441.
67. A Schmidtchen, IM Frick and L Bjorck (2001) Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol Microbiol 39 708-713.
68. FR Zaretzky, R Pearce-Pratt and DM Phillips (1995) Sulfated polyanions block Chlamydia trachomatis infection of cervix-derived human epithelia. Infect Immun 63 3520-3526.
69. BW Banfield, Y Leduc, L Esford, RJ Visalli, CR Brandt and F Tufaro (1995) Evidence for an interaction of herpes simplex virus with chondroitin sulphate proteoglycans during infection. Virology 208 531-539.
70. JF Riley, DM Shepherd and SW Stroud (1955) The function of heparin. Nature 176 1123.
71. MA Nugent (2000) Heparin sequencing brings structure to the function of complex oligosaccharides. Proc Natl Acad Sci USA 97 10301-10303.
72. RV Iozzo (2001) Series introduction. Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108 165-167.
73. CLR Merry, M Lyon, JA Deakin, JJ Hopwood and JT Gallagher (1999) Highly sensitive sequencing of the sulfated domains of Heparan sulfate. J Biol Chem 274 18455-18462.
74. L Roden, S Ananth, P Campbell, T Curenton, G Ekborg, S Manzella, D Pillion and E Meezan (1992) Heparin–an introduction. Adv Exp Med Biol 313 1-20.
75. LA Fransson, I Carlstedt, L Coster and A Malmstrom (1986) The functions of the heparan sulphate proteoglycans. Ciba Found Symp 124 125-142.
76. A Wallace, G Rovelli, J Hofsteenge and SR Stone (1987) Effect of heparin on the interaction between thrombin and hirudin. Eur J Biochem 169 373-376.
77. JM Teitel and RD Rosenberg (1983) Protection of factor Xa from neutralization by the heparin-antithrombin complex. J Clin Invest 71 1383-1391.
78. MJ Leonardi, ML McGory and CY Ko (2006) The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg 141 790-797.
79. S Soker, D Goldstaub, CM Svahn, I Vlodavsky, BZ Levi and G Neufeld (1994) Variations in the size and sulfation of heparin modulate the effect of heparin on the binding of VEGF165 to its receptors. Biochem Biophys Res Commun 203 1339-1347.
80. ML Springer, A Banfi, J Ye, G von Degenfeld, PE Kraft, SA Saini, NK Kapasi and HM Blau (2007) Localization of vascular response to VEGF is not dependent on heparin binding. FASEB J 21 2074-2085.
81. L Jakobsson, J Kreuger, K Holmborn, L Lundin, I Eriksson, L Kjellen and L Claesson-Welsh (2006) Heparan sulfate in trans potentiates VEGFR-mediated angiogenesis. Dev Cell 10 625-634.
82. M Pyda, K Korybalska, K Ksiazek, S Grajek, M Lanocha, M Lesiak, J Wisniewska-Elnur, A Olasinska, A Breborowicz, A Cieslinski and J Witowski (2006) Effect of heparin on blood vascular endothelial growth factor levels in patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol 98 902-905.
83. AB Moy, K Blackwell, MH Wu and HJ Granger (2006) Growth factor- and heparin-dependent regulation of constitutive and agonist-mediated human endothelial barrier function. Am J Physiol Heart Circ Physiol 291 H2126-H2135.
84. ES Wijelath, S Rahman, M Namekata, J Murray, T Nishimura, Z Mostafavi-Pour, Y Patel, Y Suda, MJ Humphries and M Sobel (2006) Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain: enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism. Circ Res 99 853-860.
85. M Mitsi, Z Hong and CE Costello (2006) Nugent MA, Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites. Biochemistry 45 10319-10328.
86. NJ Harmer (2006) Insights into the role of heparan sulphate in fibroblast growth factor signalling. Biochem Soc Trans 34 442-445.
87. RA Jackson, V Nurcombe and SM Cool (2006) Coordinated fibroblast growth factor and heparan sulfate regulation of osteogenesis. Gene 379 79-91.
88. A Wiedlocha and V Sorensen (2004) Signaling, internalization, and intracellular activity of fibroblast growth factor. Curr Top Microbiol Immunol 286 45-79.
89. R Rajgopal, M Butcher, JI Weitz and SG Shaughnessy (2006) Heparin synergistically enhances interleukin-11 signaling through up-regulation of the MAPK pathway. J Biol Chem 281 20780-20787.
90. VB Mehta and GE Besner (2005) Heparin-binding epidermal growth factor-like growth factor inhibits cytokine-induced NF-kappa B activation and nitric oxide production via activation of the phosphatidylinositol 3-kinase pathway. J Immunol 175(3), 1911-1918.
91. Y Chu, R Piper, S Richardson, Y Watanabe, P Patel and DD Heistad (2006) Endocytosis of extracellular superoxide dismutase into endothelial cells: role of the heparin-binding domain. Arterioscler Thromb Vasc Biol 26 1985-1990.
92. E Tkachenko, JM Rhodes and M Simons (2005) Syndecans: new kids on the signaling block. Circ Res 96 488-500.
93. V Kainulainen, H Wang, C Schick and M Bernfield (1998) Syndecans, heparan sulfate proteoglycans, maintain the proteolytic balance of acute wound fluids. J Biol Chem 273 11563-11569.
94. DL Rabenstein (2002) Heparin and heparan sulfate: structure and function. Nat Pro Rep 19 312-331.
95. RV Iozzo and JD San Antonio (2001) Heparan sulfate proteoglycans: heavy hitters in the angiogenesis arena. J Clin Invest 108 349-355.
96. E Papakonstantinou, G Karakiulakis, M Roth and LH Block (1995) Platelet-derived growth factor stimulates the secretion of hyaluronic acid by proliferating human vascular smooth muscle cells. Proc Natl Acad Sci USA 92 9881-9885.
97. E Papakonstantinou, M Roth, O Eickelberg, V Mirtsou-Fidani, M Mora and G Karakiulakis (1997) Hyaluronic acid isolated and purified from human atherosclerotic aortas is involved in the progression of atheromatosis. Biochem Biophyss Newslet 43 52-54.
98. E Papakonstantinou, G Karakiulakis, O Eickelberg, AP Perruchoud, LH Block and M Roth (1998) A 340-kDa hyaluronic acid secreted by human vascular smooth muscle cells regulates their proliferation and migration. Glycobiol 8 821-830.
99. E Papakonstantinou, M Roth, LH Block, V Mirtsou-Fidani, P Argiridis and G Karakiulakis (1998) The differential expression of hyaluronic acid in the layers of human atheromatic aortas is associated with vascular smooth muscle cell proliferation and invasion. Atheroscl 138 79-89.
100. TC Laurent and JR Fraser (1992) Hyaluronan. FASEB J 6 2397-2404.
101. M Mohamadzadeh, H DeGrendele, H Arizpe, P Estess and M Siegelman (1998) Proinflammatory stimuli regulate endothelial hyaluronan expression and CD44/HA-dependent primary adhesion. J Clin Invest 101 97-108.
102. S Adamia, CA Maxwell and LM Pilarski (2005) Hyaluronan and hyaluronan synthases: potential therapeutic targets in cancer. Curr Drug Targets Cardiovasc Haematol Disord 5 3-14.
103. CC Termeer, J Hennies, U Voith, T Ahrens, JM Weiss, P Prehm and JC Simon (2000) Oligosaccharides of hyaluronan are potent activators of dendritic cells. J Immunol 165 1863-1870.
104. C Termeer, F Benedix, J Sleeman, C Fieber, U Voith, T Ahrens, K Miyake, M Freudenberg, C Galanos and JC Simon (2002) Oligosaccharides of hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med 195 99-111.
105. KR Taylor, JM Trowbridge, JA Rudisill, CC Termeer, JC Simon and RL Gallo (2004) Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem 279 17079-17084.
106. N Itano and K Kimata (2000) Mammalian hyaluronan synthases. IUBMB Life 2002 Hynes WL, Walton SL. Hyaluronidases of Gram-positive bacteria. FEMS Microbiol Lett 183 201-207.
107. CA de la Motte, VC Hascall, J Drazba and SK Bandyopadhyay (2003) Strong SA, mononuclear leukocytes bind to specific hyaluronan structures on colon mucosal smooth muscle cells treated with polyinosinic acid:polycytidylic acid:inter-alpha-trypsin inhibitor is crucial to structure and function. Am J Pathol 163 121-133.
108. AK Majors, RC Austin, CA de la Motte, RE Pyeritz, VC Hascall, SP Kessler, G Sen and SA Strong (2003) Endoplasmic reticulum stress induces hyaluronan deposition and leukocyte adhesion. J Biol Chem 278 47223-47231.
109. MH Siegelman, HC DeGrendele and P Estess (1999) Activation and interaction of CD44 and hyaluronan in immunological systems. J Leukoc Biol 66 315-321.
110. P Johnson, A Maiti, KL Brown and R Li (2000) A role for the cell adhesion molecule CD44 and sulfation in leukocyte-endothelial cell adhesion during an inflammatory response? Biochem Pharmacol 59 455-465.
111. I Koshiishi, M Shizari and CB Underhill (1994) CD44 can mediate the adhesion of platelets to hyaluronan. Blood 84 390-396.
112. EA Turley, PW Noble and LY Bourguignon (2002) Signaling properties of hyaluronan receptors. J Biol Chem 277 4589-4592.
113. BP Toole (2004) Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer 4 528-539.
114. CM Milner and AJ Day (2003) TSG-6: a multifunctional protein associated with inflammation. J Cell Sci 116 1863-1873.
115. J Lesley, I Gal, DJ Mahoney, MR Cordell, MS Rugg, R Hyman, A Day and K Mikecz (2004) TSG-6 modulates the interaction between hyaluronan and cell surface CD44. J Biol Chem 279 25745-25754.
116. L Gossec and M Dougados (2004) Intra-articular treatments in osteoarthritis: from the symptomatic to the structure modifying. Ann Rheum Dis 63 478-482.
117. JE Christner, JJ Distler and GW Jourdian (1979) Biosynthesis of keratan sulfate: purification and properties of a galactosyltransferase from bovine cornea. Arch Biochem Biophys 192 548-558.
118. S Degroote, JM Lo-Guidice, G Strecker, MP Ducourouble, P Roussel and G Lamblin (1997) Characterization of an N-acetylglucosamine-6-O-sulfotransferase from human respiratory mucosa active on mucin carbohydrate chains. J Biol Chem 72 29493-29501.
119. K Uchimura, H Muramatsu, K Kadomatsu, QW Fan, N Kurosawa, C Mitsuoka, R Kannagi, O Habuchi and T Muramatsu (1998) Molecular cloning and characterization of an N-acetylglucosamine-6-O-sulfotransferase. J Biol Chem 273 22577-22583.
120. T Krusius, J Finne, RK Margolis and RU Margolis (1986) Identification of an O-glycosidic mannose-linked sialylated tetrasaccharide and keratan sulfate oligosaccharides in the chondroitin sulfate proteoglycan of brain. J Biol Chem 261 8237-8242.
121. IA Nieduszynski, TN Huckerby, JM Dickenson, GM Brown, GH Tai, HG Morris and S Eady (1990) There are two major types of skeletal keratan sulphates. Biochem J 271 243-245.
122. R Praus and I Brettschneider (1975) Glycosaminoglycans in embryonic and postnatal human cornea. Ophthal Res 7 452-458.
123. GM Brown, TN Huckerby, MT Bayliss and IA Nieduszynski (1998) Human aggrecan keratan sulfate undergoes structural changes during adolescent development. J Biol Chem 273 26408-26414.
124. RA Graham, TC Li, ID Cooke and JD Aplin (1994) Keratan sulphate as a secretory product of human endometrium: cyclic expression in normal women. Hum Reprod 9 926-9230.
125. JL Funderburgh, RR Mitschler, ML Funderburgh, MR Roth, SK Chapes and GW Conrad (1997) Macrophage receptors for lumican. A corneal keratan sulfate proteoglycan. Invest Ophthalmol Vis Sci 38 1159-1167.
126. LM Corpuz, JL Funderburgh, ML Funderburgh, GW Bottomley, S Prakash and GW Conrad (1996) Molecular cloning and tissue distribution of keratocan. Bovine corneal keratan sulfate proteoglycan 37A. J Biol Chem 271 9759-9763.
127. FP Barry, LC Rosenberg, JU Gaw, TJ Koob and PJ Neame (1995) N- and O-linked keratan sulfate on the hyaluronan binding region of aggrecan from mature and immature bovine cartilage. J Biol Chem 270 20516-20524.
128. CR Flannery, CB Little and B Caterson (1998) Molecular cloning and sequence analysis of the aggrecan interglobular domain from porcine, equine, bovine and ovine cartilage: comparison of proteinase-susceptible regions and sites of keratan sulfate substitution. Matrix Biol 16 507-511.
129. JD Aplin, NA Hey and RA Graham (1998) Human endometrial MUC1 carries keratan sulfate: characteristic glycoforms in the luminal epithelium at receptivity. Glycobiology 8 269-276.
130. AL Tuhkanen, M Tammi and R Tammi (1997) CD44 substituted with heparan sulfate and endo-beta- galactosidase-sensitive oligosaccharides: a major proteoglycan in adult human epidermis. J Invest Dermatol 109 213-218.
131. IA Schafer and JM Sorrell (1993) Human keratinocytes contain keratin filaments that are glycosylated with keratan sulfate. Exp Cell Res 207 213-219.
132. M Domowicz, H Li, A Hennig, J Henry, BM Vertel and NB Schwartz (1995) The biochemically and immunologically distinct CSPG of notochord is a product of the aggrecan gene. Dev Biol 171 655-664.
133. H Seo and EE Geisert (1995) A keratan sulfate proteoglycan marks the boundaries in the cortical barrel fields of the adult rat. Neurosci Lett 197 13-16.
134. SS Carlson, M Iwata and TN Wight (1996) A chondroitin sulfate/keratan sulfate proteoglycan, PG-1000, forms complexes which are concentrated in the reticular laminae of electric organ basement membranes. Matrix Biol 15 281-292.
135. MA Burg and GJ Cole (1994) Claustrin, an antiadhesive neural keratan sulfate proteoglycan, is structurally related to MAP1B. J Neurobiol 25 1-22.
136. S Chakravarti, T Magnuson, JH Lass, KJ Jepsen, C LaMantia and H Carroll (1998) Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 141 1277-1286.
137. L Olsson, M Stigson, R Perris, JM Sorrell and J Lofberg (1996) Distribution of keratan sulphate and chondroitin sulphate in wild type and white mutant axolotl embryos during neural crest cell migration. Pigment Cell Res 9 5-17.
138. A Guerassimov, Y Zhang, A Cartman, LC Rosenberg, J Esdaile, MA Fitzcharles and AR Poole (1999) Immune responses to cartilage link protein and the G1 domain of proteoglycan aggrecan in patients with osteoarthritis. Arthritis Rheum 42 527-533.
139. http://www.healthheritageresearch.com/Heparin-Conntact9608.html
140. MA Kaye and M Stacey (1950) Observations on the chemistry of hyaluronic acid. Process Biochem 2 13.
141. RA Dwek (1995) Glycobiology: more functions for oligosaccharides. Science 269 1234-1235.